Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6859-99-0

Post Buying Request

6859-99-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6859-99-0 Usage

Description

3-Hydroxypiperidine is a heterocyclic organic compound with the chemical formula C5H9NO2. It features a piperidine ring structure with a hydroxyl group attached to the third carbon atom. 3-Hydroxypiperidine is a versatile intermediate in organic synthesis and has various applications in the pharmaceutical and chemical industries.

Uses

Used in Pharmaceutical Industry:
3-Hydroxypiperidine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its presence in the molecule allows for the formation of diverse chemical structures with potential therapeutic properties.
Used in Organic Synthesis:
3-Hydroxypiperidine is used as a building block for the synthesis of unsymmetrical ureas, which are important in the development of agrochemicals and pharmaceuticals. The hydroxyl group can be converted into an isocyanate group, facilitating the formation of urea linkages.
Used in Nucleoside Analog Synthesis:
3-Hydroxypiperidine serves as a starting material for the synthesis of piperidine nucleoside analogs. These analogs are of interest in medicinal chemistry due to their potential antiviral and anticancer properties.
Used in Fluorination Reactions:
3-Hydroxypiperidine can be employed in fluorination reactions to introduce fluorine atoms into the molecule. Fluorinated compounds often exhibit improved pharmacokinetic properties, making them valuable in drug development.
Used in Heterocyclic Chemistry:
3-Hydroxypiperidine is used in the synthesis of substituted pyridines, which are important in various chemical and pharmaceutical applications. The presence of the hydroxyl group allows for further functionalization and diversification of the pyridine core.
Used in Specialty Chemicals:
3-Hydroxypiperidine is used as a precursor for the synthesis of 2-pyrrolidinone via oxidation with iodosylbenzene. 3-Hydroxypiperidine is an important solvent and intermediate in the production of various chemicals.
Used in Advanced Synthesis:
3-Hydroxypiperidine may be used to synthesize 1-[2,8-bis(trifluoromethyl)quinolin-4-yl]piperidin-3-ol through a reaction with 4-bromoquinoline. This complex molecule could have potential applications in various fields, such as materials science or medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 6859-99-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,8,5 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6859-99:
(6*6)+(5*8)+(4*5)+(3*9)+(2*9)+(1*9)=150
150 % 10 = 0
So 6859-99-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO/c7-5-2-1-3-6-4-5/h5-7H,1-4H2/p+1/t5-/m1/s1

6859-99-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (56210)  3-Hydroxypiperidine  ≥98.0% (NT)

  • 6859-99-0

  • 56210-10G

  • 522.99CNY

  • Detail
  • Aldrich

  • (56210)  3-Hydroxypiperidine  ≥98.0% (NT)

  • 6859-99-0

  • 56210-50G

  • 1,983.15CNY

  • Detail

6859-99-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Hydroxypiperidine

1.2 Other means of identification

Product number -
Other names piperidin-3-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6859-99-0 SDS

6859-99-0Synthetic route

3-HYDROXYPYRIDINE

3-HYDROXYPYRIDINE

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

1-benzyl-3-hydroxypiperidine
14813-01-5

1-benzyl-3-hydroxypiperidine

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

Conditions
ConditionsYield
With hydrogen; palladium on carbon In tetrahydrofuran; methanol under 2585.81 Torr; for 16h;98%
5-chloro-2-hydroxypentylamine hydrochloride

5-chloro-2-hydroxypentylamine hydrochloride

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

Conditions
ConditionsYield
With sodium hydroxide In water at 10 - 50℃; for 7h;85%
5-bromo-2-hydroxypentylamine hydrobromide

5-bromo-2-hydroxypentylamine hydrobromide

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

Conditions
ConditionsYield
With sodium carbonate In water at 10 - 40℃; for 5h;80%
1-trimethylsilanyl-1,2,3,6-tetrahydro-pyridine
6612-51-7

1-trimethylsilanyl-1,2,3,6-tetrahydro-pyridine

A

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

B

4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

Conditions
ConditionsYield
A 75%
B 25%
3-hydroxypyridine hydrochloride
65520-06-1

3-hydroxypyridine hydrochloride

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

Conditions
ConditionsYield
With ethanol; platinum Hydrogenation;
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

benzyl bromide
100-39-0

benzyl bromide

1-benzyl-3-hydroxypiperidine
14813-01-5

1-benzyl-3-hydroxypiperidine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃;96%
With caesium carbonate In acetone; toluene at 20℃; for 24h;88%
In methanol for 2h; Heating;
With potassium carbonate; triethylamine In tetrahydrofuran; hexane; ethyl acetate
Multi-step reaction with 2 steps
1.1: potassium carbonate / toluene / 5 h / 40 - 50 °C
1.2: 2 h / 70 - 80 °C / Inert atmosphere
2.1: ethanol / tert-butyl methyl ether / 3 h / 10 - 20 °C
View Scheme
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-tert-butoxycarbonyl-3-piperidinol
85275-45-2

N-tert-butoxycarbonyl-3-piperidinol

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;100%
With triethylamine In methanol at 20℃; for 15h;99%
With triethylamine In methanol at 20℃; for 15h;99%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

tert-butyldicarbonate
34619-03-9

tert-butyldicarbonate

N-tert-butoxycarbonyl-3-piperidinol
85275-45-2

N-tert-butoxycarbonyl-3-piperidinol

Conditions
ConditionsYield
In dichloromethane at 20℃; for 15h;87%
With triethylamine In dichloromethane at 20℃; for 1h;83.6%
With triethylamine In tetrahydrofuran; dichloromethane12.66 g (87%)
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

propargyl bromide
106-96-7

propargyl bromide

1-(prop-2-yn-1-yl)piperidin-3-ol

1-(prop-2-yn-1-yl)piperidin-3-ol

Conditions
ConditionsYield
With caesium carbonate In acetone; toluene at 20℃; for 24h; Darkness;86%
With potassium carbonate In tetrahydrofuran for 6h; Reflux;67%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

4-Fluoronitrobenzene
350-46-9

4-Fluoronitrobenzene

1-(4-nitrophenyl)piperidin-3-ol
99841-68-6

1-(4-nitrophenyl)piperidin-3-ol

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 65℃; for 6h;98%
With potassium carbonate In N-methyl-acetamide71%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

2,4-Dinitrofluorobenzene
70-34-8

2,4-Dinitrofluorobenzene

1-(2,4-dinitrophenyl)piperidine-3-ol
1012966-07-2

1-(2,4-dinitrophenyl)piperidine-3-ol

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 20℃; for 6h;91%
With potassium carbonate In dimethyl sulfoxide at 20℃; for 24h;86%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

1-(phenylsulfonyl)piperidin-3-ol
1021372-74-6

1-(phenylsulfonyl)piperidin-3-ol

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 5h; Inert atmosphere;99%
With triethylamine In dichloromethane
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

4-Fluorobenzoic acid
456-22-4

4-Fluorobenzoic acid

(4-fluoro-phenyl)-(3-hydroxy-piperidin-1-yl)-methanone
851883-00-6

(4-fluoro-phenyl)-(3-hydroxy-piperidin-1-yl)-methanone

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; benzotriazol-1-ol In dichloromethane at 20℃;53%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

6-chloro-N2-(3-chloro-4-methoxy-phenyl)-N4-cycloheptyl-[1,3,5]triazine-2,4-diamine
502767-50-2

6-chloro-N2-(3-chloro-4-methoxy-phenyl)-N4-cycloheptyl-[1,3,5]triazine-2,4-diamine

1-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazine-2-yl]-piperidin-3-ol
676360-88-6

1-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazine-2-yl]-piperidin-3-ol

Conditions
ConditionsYield
With sodium hydroxide In benzene21%
Stage #1: 3-hydroxypiperazine With sodium hydroxide In benzene for 2h; Heating / reflux;
Stage #2: 6-chloro-N2-(3-chloro-4-methoxy-phenyl)-N4-cycloheptyl-[1,3,5]triazine-2,4-diamine In benzene at 25℃; for 6h; Heating / reflux;
21%
Stage #1: 3-hydroxypiperazine With sodium hydroxide In benzene for 2h; Heating / reflux;
Stage #2: 6-chloro-N2-(3-chloro-4-methoxy-phenyl)-N4-cycloheptyl-[1,3,5]triazine-2,4-diamine In benzene at 25℃; for 6h; Heating / reflux;
21%
Stage #1: 3-hydroxypiperazine With sodium hydroxide In benzene for 2h; Heating / reflux;
Stage #2: 6-chloro-N2-(3-chloro-4-methoxy-phenyl)-N4-cycloheptyl-[1,3,5]triazine-2,4-diamine In benzene at 25℃; for 6h; Heating / reflux;
21%
Stage #1: 3-hydroxypiperazine With sodium hydroxide In benzene for 2h; Heating / reflux;
Stage #2: 6-chloro-N2-(3-chloro-4-methoxy-phenyl)-N4-cycloheptyl-[1,3,5]triazine-2,4-diamine In benzene at 25℃; for 6h; Heating / reflux;
21%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

cyclohexylcarbamic acid 2,2,2-trifluoroethyl ester

cyclohexylcarbamic acid 2,2,2-trifluoroethyl ester

3-hydroxypiperidine-1-carboxylic acid cyclohexylamide
606131-61-7

3-hydroxypiperidine-1-carboxylic acid cyclohexylamide

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 100℃; for 4h;75%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

(S)-5-chloro-N-(3-(2-methylpyrrolidin-1-yl)phenyl)thiazolo[5,4-d]pyrimidin-7-amine
1401462-29-0

(S)-5-chloro-N-(3-(2-methylpyrrolidin-1-yl)phenyl)thiazolo[5,4-d]pyrimidin-7-amine

1-(7-(3-((S)-2-methylpyrrolidin-1-yl)phenylamino)thiazolo[5,4-d]pyrimidin-5-yl)piperidin-3-ol hydrochloride

1-(7-(3-((S)-2-methylpyrrolidin-1-yl)phenylamino)thiazolo[5,4-d]pyrimidin-5-yl)piperidin-3-ol hydrochloride

Conditions
ConditionsYield
Stage #1: 3-hydroxypiperazine; (S)-5-chloro-N-(3-(2-methylpyrrolidin-1-yl)phenyl)thiazolo[5,4-d]pyrimidin-7-amine With caesium carbonate; XPhos; tris-(dibenzylideneacetone)dipalladium(0) In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;
Stage #2: With hydrogenchloride In water for 0.166667h;
51.8%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

dichloro(1,5-cyclooctadiene)palladium(II)
12107-56-1

dichloro(1,5-cyclooctadiene)palladium(II)

chloro-diphenylphosphine
1079-66-9

chloro-diphenylphosphine

C30H31Cl2NOP2Pd

C30H31Cl2NOP2Pd

Conditions
ConditionsYield
Stage #1: 3-hydroxypiperazine; chloro-diphenylphosphine With triethylamine In toluene at -78 - 20℃; for 2.5h; Schlenk technique; Inert atmosphere;
Stage #2: dichloro(1,5-cyclooctadiene)palladium(II) In toluene for 4h; Reflux; Schlenk technique; Inert atmosphere;
88%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

dichloro( 1,5-cyclooctadiene)platinum(ll)
12080-32-9

dichloro( 1,5-cyclooctadiene)platinum(ll)

chloro-diphenylphosphine
1079-66-9

chloro-diphenylphosphine

C30H31Cl2NOP2Pt

C30H31Cl2NOP2Pt

Conditions
ConditionsYield
Stage #1: 3-hydroxypiperazine; chloro-diphenylphosphine With triethylamine In toluene at -78 - 20℃; for 2.5h; Schlenk technique; Inert atmosphere;
Stage #2: dichloro( 1,5-cyclooctadiene)platinum(ll) In toluene for 4h; Reflux; Schlenk technique; Inert atmosphere;
87%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

4-(5-chloro-6-nitrothiazolo[4,5-b]pyridin-2-yl)morpholine

4-(5-chloro-6-nitrothiazolo[4,5-b]pyridin-2-yl)morpholine

1-(2-morpholino-6-nitrothiazolo[4,5-b]pyridin-5-yl)piperidin-3-ol

1-(2-morpholino-6-nitrothiazolo[4,5-b]pyridin-5-yl)piperidin-3-ol

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2h;83.33%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2h;83.33%
(5-Bromo-2-methylpentane-2-sulfonyl)benzene
794533-95-2

(5-Bromo-2-methylpentane-2-sulfonyl)benzene

3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

1-(4-benzenesulfonyl-4-methylpentyl)-3-hydroxypiperidine
794533-72-5

1-(4-benzenesulfonyl-4-methylpentyl)-3-hydroxypiperidine

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 50℃; for 18h;98%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

ethyl trifluoroacetate,
383-63-1

ethyl trifluoroacetate,

N-trifluoroacetyl-3-hydroxypiperidine
73193-62-1

N-trifluoroacetyl-3-hydroxypiperidine

Conditions
ConditionsYield
With triethylamine In ethanol at 20℃; for 8h;85%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

5-chloro-2-nitroaniline
1635-61-6

5-chloro-2-nitroaniline

5-(3'-hydroxypiperidin-1'-yl)-2-nitroaniline

5-(3'-hydroxypiperidin-1'-yl)-2-nitroaniline

Conditions
ConditionsYield
With potassium carbonate In ISOPROPYLAMIDE at 120 - 130℃; for 21h; Inert atmosphere;86%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

2-chloro-5-(trifluoromethyl)-pyrazine
799557-87-2

2-chloro-5-(trifluoromethyl)-pyrazine

1-(5-(trifluoromethyl)pyrazin-2-yl)piperidin-3-ol
1420466-40-5

1-(5-(trifluoromethyl)pyrazin-2-yl)piperidin-3-ol

Conditions
ConditionsYield
With copper(l) iodide; potassium carbonate; L-proline In dimethyl sulfoxide at 65℃; for 48h; Sealed tube;94%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

N-(3-bromopropyl)-4-nitro-1H-pyrazole
1152518-79-0

N-(3-bromopropyl)-4-nitro-1H-pyrazole

1-(3-(4-nitro-1H-pyrazol-1-yl)propyl)piperidin-3-ol
1422982-43-1

1-(3-(4-nitro-1H-pyrazol-1-yl)propyl)piperidin-3-ol

Conditions
ConditionsYield
With caesium carbonate In water; N,N-dimethyl-formamide at 20℃; for 12h;95%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

tert-butyl 4-{[4-amino-6-formyl-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f]-[1,2,4]triazin-7-yl]methyl}piperazine-1-carboxylate
1443531-81-4

tert-butyl 4-{[4-amino-6-formyl-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f]-[1,2,4]triazin-7-yl]methyl}piperazine-1-carboxylate

rac-1-{[4-amino-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)-7-(piperazin-1-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]methyl}piperidin-3-ol trihydrochloride

rac-1-{[4-amino-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)-7-(piperazin-1-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]methyl}piperidin-3-ol trihydrochloride

Conditions
ConditionsYield
Stage #1: 3-hydroxypiperazine; tert-butyl 4-{[4-amino-6-formyl-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f]-[1,2,4]triazin-7-yl]methyl}piperazine-1-carboxylate With sodium tris(acetoxy)borohydride; acetic acid In tetrahydrofuran at 60℃; for 2h;
Stage #2: With hydrogenchloride In 1,4-dioxane at 20℃;
100%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

4-((4-(4-(trifluoromethoxy)phenyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzoic acid

4-((4-(4-(trifluoromethoxy)phenyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzoic acid

(3-hydroxypiperidin-1-yl)(4-((4-(6-(trifluoromethoxy)pyridin-3-yl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)phenyl)methanone

(3-hydroxypiperidin-1-yl)(4-((4-(6-(trifluoromethoxy)pyridin-3-yl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)phenyl)methanone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; Inert atmosphere;89%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

benzenesufonyl hydrazide
80-17-1

benzenesufonyl hydrazide

1-(phenylsulfonyl)piperidin-3-ol
1021372-74-6

1-(phenylsulfonyl)piperidin-3-ol

Conditions
ConditionsYield
With tert.-butylhydroperoxide; iodine In water at 20℃; for 0.0166667h;95%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

p-bromophenylsulfonyl hydrazide
2297-64-5

p-bromophenylsulfonyl hydrazide

1-(4-bromophenylsulfonyl)piperidin-3-ol

1-(4-bromophenylsulfonyl)piperidin-3-ol

Conditions
ConditionsYield
With tert.-butylhydroperoxide; iodine In water at 20℃; for 0.0166667h;92%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

2-nitrobenzenesulfonyl hydrazide
5906-99-0

2-nitrobenzenesulfonyl hydrazide

1-(2-nitrophenylsulfonyl)piperidin-3-ol
1023119-86-9

1-(2-nitrophenylsulfonyl)piperidin-3-ol

Conditions
ConditionsYield
With tert.-butylhydroperoxide; iodine In water at 20℃; for 0.0166667h;92%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

toluene-4-sulfonic acid hydrazide
1576-35-8

toluene-4-sulfonic acid hydrazide

1-(p-toluenesulfonyl)-piperidin-3-ol
220384-68-9

1-(p-toluenesulfonyl)-piperidin-3-ol

Conditions
ConditionsYield
With tert.-butylhydroperoxide; iodine In water at 20℃; for 0.0166667h;96%
3-hydroxypiperazine
6859-99-0

3-hydroxypiperazine

acryloyl chloride
814-68-6

acryloyl chloride

1-(3-hydroxypiperidin-1-yl)-2-propen-1-one

1-(3-hydroxypiperidin-1-yl)-2-propen-1-one

Conditions
ConditionsYield
With triethylamine In dichloromethane at -10℃; for 2h;85.1%

6859-99-0Relevant articles and documents

Multi-chiral nitrogen-substituted piperidinol derivative and preparation method thereof

-

Paragraph 0017, (2021/10/11)

The invention belongs to the technical field of preparation of chiral piperidine alcohol compounds. The invention particularly relates to a multi-chiral nitrogen-substituted piperidinol derivative and a preparation method thereof. The 3 -hydroxypyridine serves as a starting raw material, and the corresponding substrate is obtained through catalytic hydrogenation reduction, amino protection, hydroxyl oxidation and Stork enamine - carbon alkylation to obtain the corresponding substrate. The process is simple, the reaction conditions are mild, and in particular, the ketone reducing liquid enzyme (KRED - 101) is selectively catalyzed, so that a chiral target product is obtained, and the yield is stable and the three wastes are few. The obtained piperidine heterocyclic derivative with the chiral center body has a plurality of drug activities and is suitable for industrial production.

Preparation method of (S)-N-BOC-3-hydroxypiperidine

-

, (2020/02/17)

The invention provides a preparation method of (S)-N-BOC-3-hydroxypiperidine. The preparation method comprises the following steps: carrying out a reaction on (S)-epichlorohydrin with a 2-chloroethylmagnesium bromide Grignard reagent to obtain (S)-1,5-dichloro-2-pentanol, carrying out an intramolecular cyclization reaction in the presence of an alkaline substance to generate (S)-5-chloro-1,2-epoxypentane, carrying out a reaction on the (S)-5-chloro-1,2-epoxypentane with an ammonia solution to generate (S)-1-amino-5-chloro-2-pentanol, then carrying out an intramolecular cyclization reaction onthe (S)-1-amino-5-chloro-2-pentanol to obtain (S)-3-hydroxypiperidine, and finally carrying out a reaction with BOC anhydride to obtain the product (S)-N-BOC-3-hydroxypiperidine. The preparation method disclosed by the invention has the advantages of short synthesis route, few side reactions and high yield; the product has good quality and is convenient for purification. The raw materials are easily available and has low price; the reaction conditions are mild; and safety is high. The preparation method is environmentally friendly, is simple and practice, and is suitable for industrial batchproduction.

Preparation method of (S)-3-hydroxypiperidine

-

Paragraph 0018-0020; 0023, (2018/06/15)

The invention discloses a preparation method of (S)-3-hydroxypiperidine. The preparation method comprises the steps of (1) carrying out catalytic hydrogenation on 3-hydroxypyridine to prepare 3-hydroxypiperidine; (2) splitting the 3-hydroxypiperidine for preparing the (S)-3-hydroxypiperidine, wherein catalytic hydrogenation is carried out under the co-catalysis of a ruthenium/silicon dioxide catalyst and a cocatalyst; the weight ratio of the ruthenium/silicon dioxide catalyst to the cocatalyst is 1:1 to 3:1; the total weight of the ruthenium/silicon dioxide catalyst and the cocatalyst is 5 to10 percent of the weight of the 3-hydroxypiperidine; and the cocatalyst is aluminum oxide. According to the method provided by the invention, the ruthenium/silicon dioxide catalyst and the aluminum oxide are adopted as a compound catalyst for catalytic hydrogenation, and the compound catalyst is relatively cheap but has the same better catalysis effect, and pollutes environment less so as to be suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6859-99-0